Aquestive Therapeutics Competitors and Similar CompaniesClear all
Aquestive Therapeutics's competitors and similar companies include InsightRX and EyePoint Pharmaceuticals.
 Aquestive Therapeutics Aquestive Therapeutics is a pharmaceutical company that is engaged in drug development using PharmFilm technology. |  InsightRX InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | |
Founding Date | Founding Date 2004 | Founding Date 2015 | Founding Date 1987 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Warren, US HQ | Locations San Francisco, US HQ | Locations Watertown, US HQ |
Employees | Employees 13017% decrease | Employees 274% increase | Employees 8453% increase |
Valuation ($) | Valuation ($) 515.4 m | Valuation ($) N/A | Valuation ($) 617.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $44.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $31.4m (FY, 2025) |
Net income | Net income ($83.8m) (FY, 2025) | Net income N/A | Net income ($232m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 12.8m | Total funding raised $ 40m |
For sources of this data, please see the company profile
View Company Profiles
InsightRX
HQ
San Francisco, US
Employees
27↑ 4% increase
InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors.
View companyEyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company